https://www.avient.com/news/mecall-srl-replaces-lead-trilliant-radiation-shielding-polyone
Replaces Lead with Trilliant™ Radiation Shielding from PolyOne
ANAHEIM, Calif. – PolyOne Corporation (NYSE: POL), a premier global provider of specialized polymer materials, services and solutions, announced that medical device manufacturer Mecall S.r.l. has replaced lead in radiology equipment with Trilliant™ Radiation Shielding solutions from PolyOne.
At working energy levels, the shielding provided by this Trilliant formulation is higher than lead, according to Mecall, resulting in the collimator operator and patient being better protected from unnecessary exposure to radiation.
https://www.avient.com/idea/medical-device-shielded-radiation-without-lead
Shielding elements protect sensitive electronic components from degradation due to X-ray exposure during a CT scan.
Teams from all three companies worked together to develop new designs based on Trilliant™ Healthcare Radiation Shielding Compound, a high-density, metallic-filled material.
The three-way collaboration allowed the manufacturer to reduce shielding component costs from 30 to 50 percent due to machining, assembly and regulatory cost reductions versus traditional methods.
https://www.avient.com/investor-center/news/advanced-composites-avient-lightweighting-solutions-fuel-efficiency
They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Masterbatch business, including any expected synergies; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; our ability to consummate and successfully integrate acquisitions; and amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions.
View original content to download multimedia:http://www.prnewswire.com/news-releases/advanced-composites-from-avient-lightweighting-solutions-for-fuel-efficiency-301299141.html
https://www.avient.com/sites/default/files/2024-05/3b - Corporate Governance Guidelines.Draft Feb. 2024.v1.2.Revised.4-16-24.Final_.pdf
Conflicts of Interest
Directors are expected to be free of outside interests that conflict with the best interests of
the Company.
The Board’s policy as to whether these roles should
be separate is to adopt the practice that best serves the Company’s needs at any particular
time.
Employee directors will resign from the Board at the time
they resign or retire from their employment with the Company, although the Board may
waive this requirement if it determines such waiver to be in the best interests of the
Company.
https://www.avient.com/news/polyone-receives-award-excellence-qsr-and-qure-medical
Homepage
//
News Center
//
PolyOne Receives Award of Excellence from QSR and Qure Medical
It’s an honor to receive this award from one of our long-standing customers,” said Robert M.
https://www.avient.com/news/cosmetic-packaging-reimagined-versaflex-pkg-thermoplastic-elastomers-polyone
Homepage
//
News Center
//
Cosmetic Packaging Reimagined with Versaflex™ PKG Thermoplastic Elastomers from PolyOne
Prevent packaging from discoloring, etching, cracking and delaminating when in contact with most soaps, lotions, oils, surfactants and solvents
https://www.avient.com/idea/pain-therapy-device-stands-out-peers
Competitive differentiation: The Biowave device is often referred to by its blue color, helping the product stand out from competitors.
Its toughness prevents the bumpers from shredding or marring, even with extensive handling.
https://www.avient.com/idea/three-things-every-paddler-wants-their-equipment
Prolong the life—and the appearance—of your vessels with UV-stable additives that protect against sun fading and deterioration from environmental exposure.
https://www.avient.com/resource-center?document_type=1071&all=1
Making the most of color: strategy, best practices, solutions
https://www.avient.com/knowledge-base/case-study/advancing-development-treated-bed-nets-malaria-control
The novel insecticides in development are formulated tightly into the masterbatch, allowing best bio-efficiency performance with a permanent but slow release to the surface—just enough to kill any mosquito by contact.